Ekaterina Dadachova, Ph.D., the Sylvia & Robert S. Olnick Faculty Scholar in Cancer Research, discusses the technology she invented with Arturo Casadevall, M.D., Ph.D., and Joshua Nosanchuk, M.D. The technology, radioimmunotherapy of metastatic melanoma with radiolabeled melanin-binding antibodies, was invented at Einstein and is now in clinical trials sponsored by Pain Therapeutics. (September 24, 2009)
Podchaser is the ultimate destination for podcast data, search, and discovery. Learn More